Skip to main content

Enrollment in the Health Benefits for Immigrant Adults (HBIA) program will be temporarily paused effective July 1, 2023.

Enrollment in the Health Benefits for Immigrant Seniors (HBIS) program will be temporarily paused effective Nov. 6, 2023.

Elizabeth M. Whitehorn, Director

Drugs and Therapeutics (D & T) Committee Meeting Results for: June 19, 2013

Drug Name Review Type Committee Recommendation Prior Approval Status � Final Determination
Invokana New Drug Initial Review Require Prior Approval Prior Approval Required
Pertzye New Drug Initial Review Require Prior Approval Prior Approval Required
Vascepa New Drug Initial Review Require Prior Approval Prior Approval Required
Myrbetriq New Drug Initial Review Require Prior Approval Prior Approval Required
Tecfidera New Drug Initial Review Require Prior Approval Prior Approval Required
Nesina New Drug Initial Review Require Prior Approval Prior Approval Required
Diclegis New Drug Initial Review Require Prior Approval Prior Approval Required
Tradjenta New Drug Appeal Require Prior Approval Prior Approval Required
Tudorza Pressair New Drug Appeal Require Prior Approval Prior Approval Required
Stribild New Drug Appeal Require Prior Approval Prior Approval Required
Humatrope PDL Appeal Require Prior Approval Prior Approval Required